Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort. - Caronna E; Mas-de-Les-Valls R; Egeo G; Vázquez MM; Castellanos CN; Membrilla JA; Vaghi G; Rodríguez-Montolio J; Fabra NF; Caballero FS; Jaimes A; Muñoz-Vendrell A; et al. (Cephalalgia : an international journal of headache, 2026)